Rita Sicuso

ORCID: 0000-0003-2604-6413
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Arrhythmias and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Cardiovascular Effects of Exercise
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Valve Diseases and Treatments
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Function and Risk Factors
  • Sports injuries and prevention
  • Healthcare Systems and Public Health
  • Cardiac Imaging and Diagnostics
  • Viral Infections and Immunology Research
  • Infective Endocarditis Diagnosis and Management
  • Cardiac Structural Anomalies and Repair
  • Aortic Disease and Treatment Approaches
  • Engineering Technology and Methodologies
  • Radiopharmaceutical Chemistry and Applications
  • Genetics and Physical Performance
  • Quality and Safety in Healthcare
  • Industrial Engineering and Technologies
  • Advanced X-ray and CT Imaging
  • Electrostatic Discharge in Electronics
  • Radioactive Decay and Measurement Techniques
  • Solid State Laser Technologies
  • Cardiovascular and exercise physiology
  • SARS-CoV-2 and COVID-19 Research

Centro Cardiologico Monzino
2018-2024

Istituti di Ricovero e Cura a Carattere Scientifico
2020-2022

Ferrarotto Hospital
2015-2018

Azienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele
2018

University of Catania
2014-2018

Background Long-term data on durability of currently available transcatheter heart valves are sparse. We sought to assess the incidence long-term (8-year) structural valve dysfunction and bioprosthetic failure in a cohort patients with aortic replacement ( TAVR ) who reached at least 5-year follow-up. Methods Results Consecutive follow-up undergoing from June 4, 2007 March 30, 2012 were included. Structural defined according newly standardized European Association Percutaneous Cardiovascular...

10.1161/jaha.117.008440 article EN cc-by-nc-nd Journal of the American Heart Association 2018-08-07

Background: Electroanatomic voltage mapping (EVM) is a promising modality for guiding endomyocardial biopsies (EMBs). However, few data support its feasibility and safety. We now report the largest cohort of patients undergoing EVM-guided EMBs to show diagnostic yield compare it with cardiac magnetic resonance (CMR)–guided approach. Methods: included 162 consecutive EMB at our institution from 2010 2019. was performed in pathological areas identified EVM CMR. CMR sensitivity specificity...

10.1161/circulationaha.120.046900 article EN Circulation 2020-08-14

Background: Arrhythmogenic left ventricular cardiomyopathy (ALVC) is an under-characterized phenotype of arrhythmogenic involving the LV ab initio. ALVC was not included in 2010 International Task Force Criteria for right diagnosis and data regarding this are scarce. Methods: Clinical characteristics were reported from all consecutive patients diagnosed with ALVC, defined as a isolated late gadolinium enhancement fibro-fatty replacement at cardiac magnetic resonance plus genetic variants...

10.1161/circep.120.009005 article EN Circulation Arrhythmia and Electrophysiology 2020-11-16

Abstract Aims To provide long-term outcome data on arrhythmogenic cardiomyopathy (ACM) patients with non-classical forms [left dominant ACM (LD-ACM) and biventricular (Bi-ACM)] an external validation of a recently proposed algorithm for ventricular arrhythmia (VA) prediction in patients. Methods results Demographic, clinical, were retrieved from all encountered at our institution. Patients classified according to disease phenotype (R-ACM; Bi-ACM; LD-ACM). Overall by survival calculated; the...

10.1093/europace/euz352 article EN EP Europace 2019-12-09

Abstract Background The novel fourth‐generation cryoballoon (CB4) potentially allows for enhanced catheter maneuverability and more frequent capture of pulmonary vein (PV) potentials which can be used to monitor real‐time PV isolation (PVI). aim our study is compare the acute procedural endpoints between CB4 second‐generation (CB2). Methods A single‐center retrospective chart review was examine 50 consecutive patients with drug‐refractory atrial fibrillation undergoing CB4‐based PVI....

10.1111/pace.13718 article EN Pacing and Clinical Electrophysiology 2019-05-02

Abstract Aims Radiofrequency catheter ablation (RFCA) represents an effective option for idiopathic premature ventricular contractions (PVCs) treatment. Ablation Index (AI) is a novel marker incorporating RF power, contact force, and time of delivery into single weighted formula. Data regarding AI-guided PVCs RFCA are currently lacking. Aim the study was to compare standard outcomes in patients with originating from right ventricle outflow tract (RVOT). Methods results Consecutive undergoing...

10.1093/europace/euaa228 article EN EP Europace 2020-07-10

Long-term data on the durability of currently available transcatheter heart valves are limited. We sought to assess four-year clinical and echocardiographic outcomes in patients undergoing aortic valve implantation (TAVI) with CoreValve prosthesis.Between June 2007 February 2014, 450 consecutive symptomatic severe stenosis underwent TAVI our institution. For purposes this study, we included only those successful prosthesis who had a minimum follow-up four years (n=125). Survival rates at...

10.4244/eijy15m10_08 article EN EuroIntervention 2016-10-01

Abstract Pulmonary vein isolation and left atrial posterior wall ablation using the Farapulse system, followed by appendage occlusion, have been achieved as single combined procedure to treat long‐standing persistent fibrillation in a patient at high hemorrhagic risk.

10.1111/pace.14823 article EN cc-by-nc Pacing and Clinical Electrophysiology 2023-09-14

A lot of studies have shown a positive effect transcatheter aortic valve implantation (TAVI) on left ventricular ejection fraction (LVEF).We aimed to investigate the TAVI function and correlate this phenomenon with hypertrophy degree in an early follow-up.Between August 2015 July 2016, 250 consecutive patients symptomatic severe stenosis (AS) underwent our institution. Given aim analysis, only LVEF <50%, no more than moderate mitral regurgitation, successful implantation, 1-month follow-up...

10.4103/jcecho.jcecho_13_18 article EN Journal of Cardiovascular Echography 2018-01-01

Abstract Embolic cerebral protection devices are not routinely used in clinical practice during electrophysiological interventions. We report a case series of patients with intracardiac thrombosis undergoing percutaneous left atrial appendage (LAA) closure and ventricular tachycardia (VT) catheter ablation supported by TriGuard 3 Cerebral Protection Device.

10.1111/pace.14712 article EN cc-by-nc Pacing and Clinical Electrophysiology 2023-05-19

Abstract Cryoballoon ablation was developed as a new treatment for pulmonary vein (PV) isolation and has demonstrated high procedural success comforting long‐term clinical outcome. However, some improvements are necessary real‐time visualization of PV signals that appeared important to increase the efficacy reduce ineffective cryoapplications. We report, first time, cryoablation procedure using fourth‐generation cryoballoon, describing betterment in signal recording acute success.

10.1111/pace.13562 article EN Pacing and Clinical Electrophysiology 2018-12-05

A new intracardiac leadless pacemaker (ILP) has been developed to ensure atrioventricular (AV) synchrony (AVS) during ventricular pacing (VP). Recent studies have shown the feasibility and safety of accelerometer-based atrial sensing an improvement in AVS among patients with block implanted Micra AV ILP (Medtronic Inc., Minneapolis, MN, USA). However, no data exists about benefits a VDD wearing still working VVI Nanostim (St Jude Medical, St Paul, We describe procedure absence device-related...

10.1093/ehjcr/ytab305 article EN cc-by-nc European Heart Journal - Case Reports 2021-08-01

Abstract The rate of post-vaccine myocarditis is being studied from the beginning massive vaccination campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although a direct cause–effect relationship has been described, in most cases, vaccine pathophysiological role doubtful. Moreover, it not quite as clear having had previous could be risk factor for disease relapse. A 27-year-old man presented to emergency department palpitations and pericardial chest pain radiated...

10.1093/eurheartj/suac018 article EN cc-by-nc European Heart Journal Supplements 2022-05-01

Abstract Background The rate of post–vaccine myocarditis is being studied from the beginning massive vaccination campaign against Sars–Cov–2, reporting a very low incidence. Although direct cause–effect relationship has been described, in most cases vaccine pathophysiological role doubtful. Moreover, it not quite as clear having had previous could be risk factor for disease relapse. Case Presentation A 27–year–old man presented to ED palpitations and pericardial chest pain radiated upper...

10.1093/eurheartj/suac011.087 article EN European Heart Journal Supplements 2022-05-01

Abstract Background Current arrhythmogenic right ventricular cardiomyopathy (ARVC) diagnostic criteria are mostly based on ventricle function and dimension. Previous studies have reported a significant overlap between ARVC chronic myocarditis, at non-invasive assessment. Purpose Tto compare biopsy-proven myocarditis patients, in order to identify clinical, imaging invasive electroanatomic voltage mapping (EVM) differences the two groups. Methods Patients with borderline diagnosis of or...

10.1093/ehjci/ehaa946.2103 article EN European Heart Journal 2020-11-01

Abstract Funding Acknowledgements Type of funding sources: None. Introduction Pulsed-field ablation (PFA) is a new non-thermal, tissue-specific technique. Through the application local electric field, it possible to induce selective electroporation cardiomyocytes membranes, resulting in myocytic apoptosis and sparing non-myocardial structures (nerves, connective tissue, esophagus, vessels). Purpose A PFA system for atrial fibrillation (AF) has recently been introduced our hospital. The aim...

10.1093/europace/euad122.124 article EN cc-by-nc-nd EP Europace 2023-05-24
Coming Soon ...